Journal of Affective Disorders
Volume 65, Issue 2 , Pages 167-171 , July 2001

Gabapentin treatment of the non-refractory bipolar spectrum: an open case series

  • S.Nassir Ghaemi

      Affiliations

    • Psychopharmacology Program, Cambridge Hospital, Consolidated Department of Psychiatry, Harvard Medical School, Cambridge, MA, USA
    • Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry and Behavioral Sciences, the George Washington University, Washington, DC, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-617-665-2525, ext. 7882; fax: +1-617-665-1149
    • ,
  • Frederick K. Goodwin

      Affiliations

    • Center on Neuroscience, Medical Progress, and Society, Department of Psychiatry and Behavioral Sciences, the George Washington University, Washington, DC, USA

Received 15 November 1999 ,Accepted 17 March 2000.

References 

  1. Altshuler L, Keck P, McElroy S, Suppes T, Brown E, Denicoff K, et al. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disorders. 1999;1:61–65
  2. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. fourth ed. Washington, DC: American Psychiatric Association; 1994;
  3. Frye, M., Ketterer, T., Kimbrell, T., Coralocatelli, G., Dunn, R., Post, R., 1997. Lamotrigine vs. gabapentin monotherapy in unipolar and bipolar illness (abstract), American Psychiatric Association Annual Meeting, San Diego, CA.
  4. Ghaemi SN, Gaughan SA. The use of novel anticonvulsants in bipolar disorder: a review of the empirical literature. Harvard Review of Psychiatry. 2000;8:1–7
  5. Ghaemi SN, Katzow JJ, Desai SP, Goodwin FK. Gabapentin treatment of mood disorders: a preliminary study. J. Clin. Psychiatry. 1998;59:426–429
  6. Guy W. Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, MD: National Institute of Mental Health; 1976;
  7. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  8. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjuntively in patients with a history of mania or hypomania. J. Affect. Disord. 1998;48:229–233
  9. Marcotte, D.B., Fogleman, L., Wolfe, N., Nemire, R., 1997. Gabapentin: an effective therapy for patients with bipolar affective disorder (abstract), American Psychiatric Association, San Diego, CA.
  10. Montouris GD. Practical insights and clinical experience with combinations of the new antiepileptic drugs. Neurology. 1995;45(Suppl. 2):S25–S28
  11. Pande A. Combination treatment in bipolar disorder (abstract). Bipolar Disorders. 1999;1(Suppl. 1):17
  12. Ryback RS, Brodsky L, Munasifi F. Gabapentin in bipolar disorder (letter). J. Neuropsychiatry. 1997;9:301
  13. Schaffer CB, Schaffer LC. Gabapentin in the treatment of bipolar disorder (letter). Am. J. Psychiatry. 1997;154:291–292
  14. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159–171
  15. Young, L.T., Robb, J., Patelis-Siotis, I., MacDonald, C., Joffe, R.T., 1997. Gabapentin in bipolar depression: a case series (abstract), American Psychiatric Association, San Diego, CA.
  16. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: Reliability, validity, and sensitivity. Br. J. Psychiatry. 1978;133:429–435

PII: S0165-0327(00)00218-4

Journal of Affective Disorders
Volume 65, Issue 2 , Pages 167-171 , July 2001

Article Tools